Raul Rosenthal, MD

Appointed
1999

Education & Fellowships

Residency - Mount Sinai Medical Center
General Surgery
New York, NY USA
1999

Residency - Beth Israel Medical Center
New York, NY USA
1997

Medical Education - Cedars-Sinai Medical Center
Endoscopic Surgery
Los Angeles, CA USA
1996

Fellowship - Cedars-Sinai Medical Center
Laparoscopic Surgery
Los Angeles, CA USA
1994

Residency - Johann Wolfgang Goethe University
Surgery
Frankfurt Main,
1991

Internship - Johann Wolfgang Goethe University
Surgery
Frankfurt Main,
1985

Internship - Provincial Hospital Rosario
Surgery
Rosario,
1984

Medical Education - University of Medicine of Rosario
Rosario,
1982

Professional Highlights

• Chairman, Department of General Surgery
• DIrector, General Surgery Residency Program
• Director, The Bariatric and Metabolic Institute, Cleveland Clinic Florida, Weston, FL
• Director, Minimally Invasive and Advanced GI Surgery Fellowship Program Cleveland Clinic Florida, Weston, FL
• Past President, South Florida Chapter, American College of Surgeons
• Past President, The Fellowship Council

Certifications

• Surgery - General Surgery

Specialty Interests

Bariatric surgery, flexible endoscopy, gastroparesis, metabolic surgery, minimally invasive surgery, surgery for achalasia, surgery for diverticulosis, surgery for gastroesophageal reflux (GERD), surgery for hiatal hernias, surgery for esophageal cancer, surgery for gastric cancer

Awards & Honors

• America's Best Doctors, 2008, 2009
• Aesculap Award, SAGES and 5th World Congress of Endoscopic Surgery. Philadelphia, PA. March 1996. "Pneumoperitoneum related changes in intracranial pressure. Observations in the large animal model."
• David Dreilling Award, Department of Surgery, The Mount Sinai Medical Center, Mount Sinai School of Medicine. "Best Academic Achievement, 1999"
• SAGES Award Best Poster Presentation. SAGES and 10th World Congress of Endoscopic Surgery. New York, New York. April 2002 "Effects of intracranial hypertension on splachnic circulation. Observations in the large animal model."
• Eduardo Schiepatti's award. Best poster presentation. 74th Congress of the Argentinian Society of Surgery. "Laparoscopic gastric bypass at Cleveland Clinic Florida"
• Director, Learning Center at the World Congress of Endoscopic Surgery. Cancun Mexico, 2004
• Director, Postgraduate Course on Obesity. Annual Meeting of the Argentinian Society of Surgery. Buenos Aires, Argentina. November 2003
• Chair, Video Session Program. SAGES, 2007, Las Vegas
• Honorary Member, Association of Minimally Invasive Surgeons of India. 2006
• Moderator, SAGES Bariatric Session. April 12, 2008, Philadelphia
• Co-Chair, SAGES / Fellowship Council Session, April 12, 2008, Philadelphia
• Honorary Member, German Society of Visceral Surgeons, Berlin, April 2008
• Honorary Member Peruvian, Bolivian, and Indian society of Surgeons.   

Memberships

• American College of Surgeons
• American Surgical Association
• Society of American Gastrointestinal and Endoscopic Surgeons
• American Society of Metabolic and Bariatric Surgeons
• German Society of Surgeons
• Argentinean Society of Surgeons

See publications for Raul Rosenthal, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 10/3/2022, Dr. Rosenthal has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Rosenthal receives fees of $5,000 or more per year (or, in rare cases, equity or stock options) as a paid consultant, speaker or as a member of an advisory committee for the following companies:

• Diagnostic Green, LLC
• Medtronic ATS Medical, Inc.
• Olympus America Inc.
• Arthrex, Inc.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.